Home Cart Sign in  
Chemical Structure| 961-29-5 Chemical Structure| 961-29-5

Structure of Isoliquiritigenin
CAS No.: 961-29-5

Chemical Structure| 961-29-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Isoliquiritigenin is an anti-tumor flavonoid from the root of Glycyrrhiza uralensis Fisch., which inhibits aldose reductase with an IC50 of 320 nM and influenza virus replication with an EC50 of 24.7 μM.

Synonyms: GU17; ISL; GU 17, Isoliquiritigenin

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Isoliquiritigenin

CAS No. :961-29-5
Formula : C15H12O4
M.W : 256.25
SMILES Code : O=C(C1=CC=C(O)C=C1O)/C=C/C2=CC=C(O)C=C2
Synonyms :
GU17; ISL; GU 17, Isoliquiritigenin
MDL No. :MFCD00075907
InChI Key :DXDRHHKMWQZJHT-FPYGCLRLSA-N
Pubchem ID :638278

Safety of Isoliquiritigenin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Related Pathways of Isoliquiritigenin

epigenetics

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
U87 cells 5 µM 48 hours To investigate the effects of ISL on circRNA expression, it was found that ISL significantly downregulated circ0030018 expression PMC10220153
SHG44 cells 5 µM 48 hours To investigate the effects of ISL on circ0030018 expression, it was found that ISL significantly downregulated circ0030018 expression PMC10220153
Mouse primary bone marrow-derived macrophages (BMMs) 16 or 64 μg/mL 5 days MSNs-ISL significantly inhibited RANKL-induced osteoclast generation, decreased the size and quantity of sealing zones, and reduced the osteolytic capacity of osteoclasts in vitro. PMC6691588
NOZ cells 0–100 mM 24 h, 48 h, 72 h ISL significantly inhibited the proliferation of NOZ cells, with IC50 values of 151.3 mmol/L at 24 h, 59.5 mmol/L at 48 h, and 54.2 mmol/L at 72 h. PMC10508381
SGC-996 cells 0–100 mM 24 h, 48 h, 72 h ISL significantly inhibited the proliferation of SGC-996 cells, with IC50 values of 210.1 mmol/L at 24 h, 72.9 mmol/L at 48 h, and 51.9 mmol/L at 72 h. PMC10508381
HiBECs cells 50 mM, 70 mM 48 h ISL at 50 mmol/L and 70 mmol/L did not significantly alter the growth of HiBECs cells. PMC10508381
L-2F7 cells 50 mM, 70 mM 48 h ISL at 50 mmol/L and 70 mmol/L did not significantly alter the growth of L-2F7 cells. PMC10508381

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
C57/BL6 mice LPS-mediated calvarial bone erosion model Subcutaneous injection 50 mg/kg Once every 2 days for 7 days MSNs-ISL could block osteoclast activity, relieve inflammation-related calvarial bone destruction in vivo, and suppress c-Fos, NFATc1, and cathepsin K expression levels. PMC6691588
BALB/c Nude mice NOZ cell xenograft model Gavage 50 mg/kg Every 2 days for 28 days ISL significantly inhibited tumor growth in the NOZ cell xenograft model, reducing tumor volume to less than 10% of the control group. HMOX1-deficient or GPX4-overexpressing NOZ cells partially reversed the inhibitory effect of ISL. PMC10508381

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

3.90mL

0.78mL

0.39mL

19.51mL

3.90mL

1.95mL

39.02mL

7.80mL

3.90mL

References

 

Historical Records

Categories